A phase 1/2 clinical study of OTO-413 in hearing loss patients.
Phase of Trial: Phase I/II
Latest Information Update: 03 Jan 2019
At a glance
- Drugs OTO-413 (Primary)
- Indications Sensorineural hearing loss
- Focus Adverse reactions; Therapeutic Use
- 03 Jan 2019 According to an Otonomy media release, the trial is expected to start in the third quarter of 2019 with results in the second half of 2020.
- 08 Mar 2018 According to an Otonomy media release, the trial expected to begin in the first half of 2019.
- 12 Feb 2018 New trial record